S1. Reduction of Adipose Mass, But No Change in Body Weight
Despite significantly decreased adipose mass in FX-fed mice, the body weight of these mice were not changed. This might be related to enlarged liver, heart and spleen in these mice (Table S1 ). Enlarged liver and spleen have also been observed in ICR mice orally administered with FX (500 or 1000 mg/kg body weight) daily for 30 days. However, no abnormal changes were observed in histological examination [1] . The dose of FX used in our study, 0.2% in the diet, is equivalent to 180~260 mg/kg body weight per day and is much lower than that study.
S2. Correlation of Adipose Mass and O 2 Consumption and CO 2 Production
As shown in Figure S1 , the O 2 consumption during the dark phase of the four groups of mice negatively correlated to the relative weight of eWAT and iWAT, but not rWAT. The CO 2 production, but not O 2 consumption, in the dark phase positively correlated to BAT mass. The CO 2 production in the dark phase negatively correlated to the relative weight of eWAT, but not to those of iWAT and rWAT. 
